Literature DB >> 2157920

Pharmacological therapy after coronary angioplasty. Early experience with low molecular weight heparin for prophylaxis of reocclusion.

T Schmidt1, U Tebbe, J Schrader, S Brune, H Kreuzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2157920     DOI： 10.1007/BF02116062

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  4 in total

1.  Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

Authors:  L Schwartz; M G Bourassa; J Lespérance; H E Aldridge; F Kazim; V A Salvatori; M Henderson; R Bonan; P R David
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

2.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

Authors:  P W Serruys; H E Luijten; K J Beatt; R Geuskens; P J de Feyter; M van den Brand; J H Reiber; H J ten Katen; G A van Es; P G Hugenholtz
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

3.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

Authors:  D R Holmes; R E Vlietstra; H C Smith; G W Vetrovec; K M Kent; M J Cowley; D P Faxon; A R Gruentzig; S F Kelsey; K M Detre
Journal:  Am J Cardiol       Date:  1984-06-15       Impact factor: 2.778

4.  Recurrence rate after successful coronary angioplasty.

Authors:  M Kaltenbach; G Kober; D Scherer; C Vallbracht
Journal:  Eur Heart J       Date:  1985-03       Impact factor: 29.983
  4 in total
  1 in total

Review 1.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.